Standout Papers

ESC Guidelines for the management of acute coronary syndromes in pat... 2005 2026 2012 2019 2.3k
  1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) (2011)
    C Hamm, Jean‐Pierre Bassand et al. European Heart Journal
  2. Guidelines for Percutaneous Coronary Interventions (2005)
    Sigmund Silber, Per Albertsson et al. European Heart Journal
  3. Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis (2007)
    Nico H.J. Pijls, Pepijn van Schaardenburgh et al. Journal of the American College of Cardiology
  4. ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation (2012)
    Christian W. Hamm, Jean‐Pierre Bassand et al. Revista Española de Cardiología (English Edition)
  5. Guidelines on myocardial revascularization (2010)
    Philippe Kolh, William Wijns et al. European Journal of Cardio-Thoracic Surgery
  6. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) (2003)
    Joachim Schofer, Michael Schlüter et al. The Lancet
  7. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. (1985)
    Johan H. C. Reiber, Patrick W. Serruys et al. Circulation
  8. Relation between Myocardial Blood Flow and the Severity of Coronary-Artery Stenosis (1994)
    Neal Uren, P. Daniel Meerburg et al. New England Journal of Medicine
  9. A Cause for Concern (2007)
    Edoardo Camenzind, Philippe Gabríel Steg et al. Circulation
  10. Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis (2001)
    G. Jan Willem Bech, Bernard De Bruyne et al. Circulation
  11. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention (2016)
    Robert W. Yeh, Eric A. Secemsky et al. JAMA
  12. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. (1993)
    Jean‐Louis Vanoverschelde, William Wijns et al. Circulation
  13. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial (2008)
    Stephan Windecker, Patrick W. Serruys et al. The Lancet
  14. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography (2016)
    Shengxian Tu, Jelmer Westra et al. JACC: Cardiovascular Interventions
  15. Cardiopoietic Stem Cell Therapy in Heart Failure (2013)
    Jozef Bartúnek, Atta Behfar et al. Journal of the American College of Cardiology
  16. Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis (2017)
    Bo Xu, Shengxian Tu et al. Journal of the American College of Cardiology
  17. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability (2018)
    Juhani Knuuti, H Ballo et al. European Heart Journal
  18. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial (2015)
    Michael Haude, Hüseyin İnce et al. The Lancet

Immediate Impact

3 by Nobel laureates 6 from Science/Nature 118 standout
Sub-graph 1 of 13

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
2019 Standout
46 intermediate papers

Works of William Wijns being referenced

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice
2006
and 32 more

Author Peers

Author Last Decade Papers Cites
William Wijns 24615 25863 19813 675 38.3k
Stephen G. Ellis 26906 26344 11774 513 40.1k
Adnan Kastrati 24140 26277 9852 768 37.8k
Albert Schömig 19676 25427 9099 600 38.8k
Bernard De Bruyne 25666 21422 23037 462 33.0k
Ron Waksman 18932 16196 8682 1.2k 28.4k
Eric Boersma 17338 29119 13107 693 39.6k
Jeffrey W. Moses 20807 17857 10354 525 29.4k
Dean J. Kereiakes 18644 19456 6501 494 27.8k
Christian W. Hamm 12335 23067 8151 838 32.2k
Lowell F. Satler 18373 16285 10570 767 26.7k

All Works

Loading papers...

Rankless by CCL
2026